Vav is a guanine-nucleotide exchange factor for the Rho-like small GTPases RhoA, Rac1 and Cdc42, which regulate cytoskeletal reorganization and activation of stress-activated protein kinases (SAPK/JNKs). Vav is expressed in hematopoietic cells and is phosphorylated in T and B cells following activation of various growth factor or antigen receptors. Vav interacts with several signaling molecules in T cells, but the functional relevance of these interactions is established only for Slp76: they cooperate to induce activity of the transcription factor NF-AT and interleukin-2 expression. We have investigated the role of Vav in T cells by generating vav -/-mice.
Background
Binding of the T-cell receptor (TCR) to antigens initiates a cascade of molecular events which result in the tyrosine phosphorylation of various proteins, Ca 2+ mobilization, activation of the signal transduction pathways involving mitogen-activated protein kinases (MAPKs) or stress-activated protein kinases (SAPKs; also known as Jun N-terminal kinases or JNKs), and reorganization of the cytoskeleton. Vav is specific for hematopoietic cells and, in T cells, Vav becomes tyrosine phosphorylated in response to T-cell activation and might play an important role in various TCR-mediated signaling pathways [1] [2] [3] . Vav might be recruited to the activated TCR via its Srchomology 2 (SH2) domain, which binds the TCR-activated proximal kinases Zap70 and Syk [4] . Previous studies using vav -/-rag -/-chimeric mice showed that Vav is required for T-cell development and proliferation mediated by TCR and CD3 [5] [6] [7] .
Vav comprises a collection of structural motifs including a pleckstrin-homology (PH) domain, which might participate in membrane localization, a calponin-homology (CH) domain, which potentially mediates actin binding, one SH2 domain and two SH3 domains, which are known to mediate protein-protein interactions, and a Dbl-homology (DH) domain [1, 8] , which catalyzes guanine-nucleotide exchange in members of the Rho family of small GTPases. Although Vav has been implicated in signaling through the Ras-MAPK pathway [1, 9, 10] , recent biochemical and genetic studies have established a function for Vav in the activation of Rac1 and other members of the Rho family [11] [12] [13] [14] [15] [16] [17] [18] [19] . Vav activation of Rho GTPases in vitro requires that it is first phosphorylated by the TCR-associated Srcfamily kinase Lck or Zap70 and the presence of phosphoinositides [20] . Rho GTPases regulate cytoskeletal reorganization as well as signaling that leads to activation of p21-activated kinase (PAK) and SAPK/JNK [11] [12] [13] [14] [15] [16] .
The presence of SH2 and SH3 domains suggest that Vav may function as an adaptor molecule, and Vav interacts with a variety of signaling molecules in T cells including Grb-2, Shc, Cbl-c, Zap70, and Slp76 [1, [20] [21] [22] [23] . The functional relevance of these interactions remains unclear with the exception of the interaction with the phosphoprotein Slp76, as Vav and Slp76 cooperate in transient transfection assays in T cells to induce activity of the transcription factor NF-AT and expression of interleukin-2 (IL-2) [20] [21] [22] [23] . It has been proposed that Vav links TCR stimulation to signaling by RhoA, Rac1 and Cdc42 and activation of the PAK and SAPK/JNK signaling cascade [17] [18] [19] . SAPK/JNK activation appears to be necessary for IL-2 production and proliferation in T cells [24] [25] [26] [27] . Additionally, Vav has been implicated in regulation of actin reorganization, as microinjection of truncated versions of Vav into fibroblasts leads to actin cytoskeletal reorganization, and Vav-transformed fibroblasts develop stress fibers and focal adhesions [28, 29] . Here we report the phenotype of viable vav -/-mice and the role of Vav in TCR-mediated signal transduction.
Results

Generation of vav -/-mice
It has been described previously that ablation of vav in D3 embryonic stem (ES) cells results in early embryonic lethality due to impaired trophoblast development and embryo implantation [30] . As Vav is preferentially expressed in hematopoietic cells that develop post implantation, we retargeted vav in R1 ES cells (Supplementary material, available with this paper on the internet). Germline transmission of the targeted allele was obtained with two independent ES cell clones. In contrast to previous results that Vav is essential for early embryogenesis, mice homozygous for the vav deletion were viable, fertile and healthy, and had no histological signs of defects or inflammation in any organ. The earlier reported embryonic lethal mutation was derived from a single vav +/-D3 ES cell clone and a second mutation may have occurred which could have have co-segregated with the targeted vav allele. Whereas expression of Vav was absent in vav -/-thymocytes, Vav2 was found to be strongly expressed in wild-type, vav +/-and vav -/-cells (Supplementary material).
Lymphocyte development in vav -/-mice
Previous investigations into the role of Vav using Rag-2 complementation assays showed that vav -/-rag -/-chimeric mice exhibit defects in lymphocyte development and CD3-mediated proliferation. It was also reported that vav -/-rag -/-chimeric mice have small thymuses, indicative of an early block in thymocyte precursor development [5] [6] [7] . We evaluated T-cell and B-cell development in our vav -/-mice. Viable vav -/-mice have normal numbers and differentiation of B220 + sIgM + B cells in the bone marrow and normal B-cell populations in peripheral lymphoid organs (Table 1 and Supplementary material), but reduced numbers of B1 (CD5 + IgM + ) B cells in the peritoneal cavity (data not shown) [6, 7] . This result contrasts with previous reports that B-cell populations were decreased in vav -/-rag -/-mice. This discrepancy may be due to the nature of Rag assays, in which substantial numbers of endogenous rag -/-B-cell progenitors are present and compete with vav -/-progenitors. Hematopoietic bone marrow progenitor assays revealed no differences among vav -/-and vav +/-mice implying that Vav is dispensable for myeloid differentiation [30] .
Viable vav -/-mice exhibit slightly reduced thymic cellularity, although no differences in the total numbers of CD4 -CD8 -cells or in the total and relative numbers of any precursor population were observed on a CD1 background. Backcrosses to C57/B6 mice (four generations) revealed an increase in the number of vav -/-CD44 -CD25 + precursor cells, however, signifying that Vav has a role in early thymic development in some inbred mouse strains (data not shown). In addition, the progression from immature CD4 + CD8 + thymocytes to mature CD4 + or CD8 + T cells was partially blocked, as the total and relative frequency of mature CD4 + or CD8 + thymocytes was significantly reduced in vav -/-mice on both CD1 and C57/Bl6 backgrounds. Consistent with a defect in lymphocyte development, the absolute and relative numbers of peripheral CD4 + and CD8 + T cells were also reduced (Table 1 Cells from thymi, mesenteric lymph nodes and spleens from vav +/-(n = 6) and vav -/-(n = 6) littermate mice were stained with antibodies against the indicated proteins and populations determined using a FACScan. Bold numbers indicate statistically significant differences between vav +/-and vav -/-T-cell subpopulations (Student's t-test; p < 0.05). Values are given as the mean ± the standard error of the mean.
thymocytes and peripheral T cells (data not shown). The difference between viable vav -/-mice and vav -/-rag -/-chimeras implies that vav -/-thymocyte precursor cells have a partial defect in colonization of the thymus and may compete for developmental niches with normal cells in the chimeric animals. The identification of these developmental niches and of differences in thymocyte precursor maturation, which might depend on the inbred mouse strain, requires further studies.
Impaired antigen-receptor activation
To determine the functional consequence of the vav mutation in T cells, we activated purified lymph node T cells using phorbol 12-myristate 13-acetate (PMA) and Ca 2+ ionophore, which mimic downstream events in TCR/CD3-mediated signal transduction, or using anti-CD3ε antibody. Whereas both vav +/-and vav -/-T cells responded in the same way to PMA plus Ca 2+ ionophore, stimulation with anti-CD3ε antibody revealed a dramatic decrease in the proliferation of vav -/-T cells. The proliferation block was partially overcome by the addition of IL-2 ( Figure 1a) . Although co-stimulation of wild-type cells with anti-CD3 and anti-CD28 antibodies resulted in significantly higher levels of IL-2 production, co-stimulation of vav -/-T cells with anti-CD3 and anti-CD28 antibodies had no additional affect on IL-2 production and did not increase proliferation (data not shown). Thus, in the context of IL-2 production we cannot discriminate between a function for Vav downstream of TCR and/or CD28. Consistent with a block in TCR-mediated proliferation, vav -/-T cells did not upregulate expression of the transcription factor NF-ATc1, or downregulate expression of the inhibitor of cyclin-dependent kinases (CDKs) p27 Kip1 (Figure 1b) . T cells that were deficient for vav were blocked at the G1 phase of the cell cycle but did not undergo enhanced apoptosis after TCR/CD3 activation (data not shown). These results demonstrate that Vav is essential for antigen-receptor signaling leading to proliferation and IL-2 production.
TCR-mediated signal transduction in vav -/-T cells
To elucidate the biochemical mechanism that accounts for the functional defect in vav -/-T cells, we analyzed signaling Anti-CD3ε activated with anti-CD3ε (1 µg/ml) plus anti-CD28 (10 µg/ml) antibodies, or PMA (50 ng/ml) plus Ca 2+ ionophore (Ca-I; 500 ng/ml) for the indicated time periods. SAPK/JNK was immunoprecipitated and assayed for in vitro kinase activity using a glutathione-S-transferase (GST)-c-Jun fusion protein as the substrate. MAPK activity was assayed using myelin basic protein (MBP) as substrate. One result representative of three experiments is shown. (f) Ca 2+ fluxes in freshly isolated thymocytes from vav +/-and vav -/-mice: the X axis shows realtime Ca 2+ release and the Y axis shows the intensity of the increase in intracellular [Ca 2+ ] after CD3ε cross-linking (1 µg/ml of cross-linking antibody). The intensity of the Ca 2+ flux was dependent on the concentration of the cross-linking antibody (data not shown).
also examined the clustering of antigen receptors into polarized cap structures, a process that is known to require a functional cytoskeleton [31, 32] . In contrast to vav +/-T cells, vav -/-lymph node T cells (Supplementary material) and thymocytes (data not shown) did not form caps following TCR/CD3 cross-linking. T cells deficient for vav did, however, cap the GPI-linked Thy1.2 surface molecule [33] indicating that the impairment in CD3 capping in vav -/-T cells is not due to a general capping defect. Treatment of vav +/-T cells with cytochalasin D inhibited not only TCR clustering, but also IL-2 production and proliferation (data not shown).
Vav in actin cytoskeleton reorganization
The experiments described so far suggested that Vav may regulate actin-dependent processes in T cells and thymocytes. To test this hypothesis, we examined Vav interactions with proteins that are associated with the actin cytoskeleton. Vav co-immunoprecipitated with vinculin (data not shown) and talin ( Figure 5a ) independently of CD3 cross-linking. The Vav-associated protein Slp76 was present in talin immune complexes from stimulated vav +/-T cells, and this association was abrogated in vav -/-T cells (Figure 5a ). Consistent with a role for Vav in linking TCR signals to the cytoskeleton, TCR-triggered interactions of actin with CD3ζ [34] did not occur in vav -/-T cells (Figure 5b) . Interestingly, TCR-mediated tyrosine phosphorylation of Slp76 was significantly impaired in the absence of Vav expression (Figure 5c ). These results indicate that Vav links antigen-receptor signaling to receptor clustering, Slp76 phosphorylation, Slp76-talin interactions, and recruitment of the actin cytoskeleton to CD3ζ.
Vav links TCR signaling to actin polymerization
The activation of TCR induces actin polymerization in T lymphocytes [31, [34] [35] [36] . To test the requirement for Vav in this process, we stimulated thymocytes (Figure 6a ) and purified lymph node T cells (Figure 6b,d ) with an anti-CD3ε antibody and analyzed actin polymerization quantitatively on a single-cell basis using phalloidin labeled with fluorescein isothiocyanate (FITC) which binds to polymerized, filamentous (F) actin. Whereas TCR triggering in vav +/-thymocytes ( Figure 6a ) and peripheral T cells (Figure 6b ) induced significant actin polymerization in a time-dependent manner, vav -/-cells exhibited a severe defect in antigen-receptor-mediated actin polymerization. PMA-mediated actin polymerization was unaffected in vav -/-thymocytes (data not shown) and lymph node T cells (Figure 6c ). Actin polymerization was not enhanced by the co-stimulation of CD28 with anti-CD3ε antibody, nor was it induced by the cross-linking of CD28 alone (data not shown). In addition, induction of Ca 2+ mobilization by the Ca 2+ ionophore A23617 (100 ng/ml) did not enhance TCR-mediated actin polymerization and could not compensate for the actin-polymerization defect in vav -/-thymocytes and lymph node T cells (data not shown).
Discussion
We have ablated the vav gene and report the phenotype of vav -/-mice. Our data suggest that Vav regulates several TCR-mediated processes: in mature T cells, transcriptional induction of NF-ATc1, IL-2 production and proliferation; and in thymocytes, maturation. Remarkably, despite the severe impairment in physiological T-cell functions, principle TCR-mediated signaling pathways including MAPK and SAPK/JNK activation were functional in vav -/-T cells. Moreover, Vav has no apparent role in the tyrosine phosphorylation of Zap70, Cbl-c or CD3ζ, IκB-α phosphorylation, or activation of p38/Hog, PAK or 
The observations that stimulated TCRs fail to cluster and induce F-actin formation only weakly in vav -/-T cells show that Vav is a specific regulator of actin cytoskeletal reorganization mediated by the antigen receptor in T cells.
In support of these findings is the observation that inhibition of actin polymerization using cytochalasin D blocks IL-2 production, proliferation, and the induction of TCRmediated transcription, but does not impair MAPK and SAPK/JNK pathways, or overall cellular phosphorylation (see also the accompanying report by Holsinger et al. [37] ). The importance of a functional cytoskeleton for sustained signaling and interferon-γ production has been previously noted in human CD4 + T-cell clones following activation with peptide-loaded antigen-presenting cells [35] . In contrast to our experiments, however, cytochalasin D had no effect on T-cell responses following cross-linking using an anti-CD3 antibody [35] . The discrepancy might be explained by the different cells used in these experiments and quantitative differences in CD3 cross-linking.
Vav binds constitutively to both talin and vinculin, which anchor the actin cytoskeleton to the cell membrane and co-localize with the oligomerized TCR. Importantly, Vav is required for normal phosphorylation of Slp6, a protein which binds to the Vav SH2 domain. In cooperation with Vav, Slp76 augments TCR-induced IL-2 production in transient expression systems [21] [22] [23] . In the absence of Vav, activation-dependent association of Slp76 with talin is impaired and CD3ζ fails to recruit actin to the TCR complex. Thus, Vav might serve as an adaptor that links cytoskeletal and signaling molecules to actin. After activation of the TCR, Vav bound to talin and to vinculin becomes rapidly phosphorylated and associates with Slp76.
A complex consisting of Vav, Slp76, talin and vinculin might then trigger actin polymerization and the recruitment of the actin cytoskeleton to the antigen receptor. the full T-cell response invoked by multimerized TCRs (Figure 7) . Thus, antigen-receptor activation might lead to the organization of focal actin-scaffolded signaling 'highways' [41] [42] [43] . Our results offer a biochemical rationale for receptor reorganization and clustering; that is, actindependent receptor clustering results in signal transduction at regionally organized focal points as a prerequisite for the induction of physiological responses. Contact between TCRs and ligand over an extended length of time in vivo might enable sustained signaling to result from limiting amounts of the peptide ligand. Moreover, proliferation and cytokine production are lymphocyte responses that occur several hours after stimulation and require prolonged activation. Actin cytoskeleton reorganization into caps might also trigger close packing of costimulatory molecules with activated TCRs and the expulsion of negative regulators of signaling [44, 45] . Our data provide the first genetic evidence for a role for Vav in cytoskeletal reorganization in vivo and show that Vav-regulated receptor clustering and actin polymerization are essential prerequisites for lymphocyte maturation, cell cycle progression, and IL-2 production in T cells.
Although the SAPK/JNK pathway is activated by Rac1 and Cdc42 and is still functional in vav -/-T cells, the normal induction of SAPK/JNK in the vav -/-T cells does not preclude the possibility that Vav serves as a link between cytoskeletal proteins and the small GTPases
Materials and methods
Gene targeting
Isolation of a 129/J genomic vav fragment and targeting vectors were as described [30] . The construct was introduced into R1 ES cells and G418-resistant ES colonies were screened for homologous recombination by PCR and Southern blotting. Germline transmission of the targeted allele was obtained with two independent ES cell clones. The vav mutation was bred to an outbred (CD1) background and into three inbred backgrounds (C57BL/6, 129/J, BALB/c). All results shown in this report were from vav -/-CD1 mice. Mice were maintained under pathogen-free conditions in accordance with guidelines of the Canadian Medical Research Council.
Immunofluorescence
Single cell suspensions of thymocytes, mesenteric lymph nodes, bone marrow, and spleens from vav +/-and vav -/-mice were stained in immunofluorescence staining buffer (PBS, 1% fetal calf serum (FCS), 0.01% NaN 3 ). The following antibodies were used: anti-CD4 (labeled with polycoerythrin; PE), anti-CD8 (labeled with FITC), anti-CD3ε antibodies. B cells were stained using anti-B220 (labeled with PE), anti-CD19 (biotinylated), anti-sIgM (labeled with FITC), anti-sIgD (biotinylated), anti-CD43 (labeled with FITC), anti-CD5 (labeled with FITC), and anti-CD25 (biotinylated) antibodies. All antibodies were from PharMingen. Biotinylated antibodies were visualized using Streptavidin RED670 (Life Technologies). Samples were analyzed on a FACScan (Becton Dickinson).
T-cell proliferation
T cells were enriched from lymph nodes of vav -/-and vav +/-mice using affinity columns to avoid receptor cross-linking during the purification process (R&D Systems 
Signal transduction and immunoprecipitation
Thymocytes or purified lymph node T cells (5 × 10 6 ) were activated with either PMA, Ca 2+ ionophore or soluble anti-CD3ε and anti-CD28 antibodies as described [24, 27, 46] . Tyrosine phosphorylation was monitored using an anti-phosphotyrosine monoclonal antibody (UBI). Activated SAPK/JNKs, MAPKs, PKB/AKT and p38 were detected using antibodies specific for the phosphorylated proteins which are indicative of activation (New England Biolabs). The levels of SAPK/JNK, MAPKs (ERK1/ERK2), and p38/Hog were determined by immunoblotting (New England Biolabs). For in vitro kinase assays, cells were lysed in lysis buffer containing 0.5% NP-40 [24, 27, 46] and MAPK/ERKs and SAPK/JNKs were immunoprecipitated for 1 h at 4°C using a mixture of polyclonal rabbit anti-ERK1 and anti-ERK2 IgG (Santa Cruz), or polyclonal rabbit anti-SAPK/JNK IgG reactive against all SAPK/JNK isoforms. SAPK/JNK and MAPK assays were performed using GST-c-Jun or MBP as in vitro substrates for SAPK/JNK and MAPK (ERK1/ERK2), respectively. PAK activity was detected in an ingel kinase assay using MBP as substrate [15] . Phosphorylated IκB-α was detected using a monoclonal antibody specific to phosphoserine (Ser32) of IκB-α (New England Biolabs). Ser32 phosphorylation of IκB-α targets IκB to degradation and is essential for release of active NF-κB [47] .
Co-immunoprecipitations of Vav (using an anti-Vav antibody against amino acids 576-589, Santa Cruz) with vinculin (anti-vinculin antibody, Sigma), talin (anti-talin antibody, Sigma), and actin (anti-actin antibody, Sigma) were as described [34, 48] . Slp76 was detected using an antiSlp76 polyclonal antibody (Upstate Biotechnology) and Slp76 immunoprecipitations were performed with a polyclonal sheep antimouse antibody (gift of G. Koretzky). CD3ζ was detected using a polyclonal rabbit anti-CD3ζ antibody (gifts of R. Klausner) and CD3ζ immunoprecipitations were performed with a mouse anti-CD3ζ monoclonal antibody (Zymogen). Zap70 (anti-Zap70 antibody, gift of A. Chan) immunoprecipitations and western blots were performed as described [48] .
Ca 2+ signaling
For detection of the intracellular Ca 2+ concentration, freshly isolated thymocytes (5 × 10 6 ) were loaded with 3 mM INDO-1 (Molecular Probes) in IMDM (pH 7.4) for 1 h at 37°C. After INDO-1 loading, thymocytes were incubated with anti-CD3ε antibody (clone KT3, 1 µg/ml) for 30 min at 4°C. Cells were washed and CD3ε molecules were cross-linked using goat anti-rat IgG (Jackson Laboratories). Increases in intracellular free Ca 2+ concentrations were recorded in real time for 600 sec on live gated cells using a FACScalibur (Becton Dickinson).
Receptor capping and confocal microscopy
Thymocytes and lymph node T cells were incubated with anti-CD3ε (clone 145-2C11, hamster IgG) for 30 min at 4°C or 37°C. Cells were then washed and primary antibodies cross-linked using biotinylated goat anti-hamster antibodies (20 min, 4°C or 37°C). Receptor capping was stopped by addition of 0.2% sodium azide. Cells were transferred onto slides using cytospin. CD3 caps were identified using Streptavidin RED670 (Life Technologies). Talin, vinculin, Rac1, Rac2, RhoA and Cdc42 were co-localized with the CD3 caps using indirect immunofluorescence of anti-talin, anti-vinculin (Sigma), antiRhoA, anti-Rac1, anti-Rac2, and anti-Cdc42 antibodies (Santa Cruz), followed by FITC-labeled goat anti-mouse or goat anti-rabbit IgG. For Thy1.2 capping, thymocytes were incubated with a mouse anti-Thy1.2 antibody (clone AT83) and the primary antibody cross-linked by goat anti-mouse as described above. Specimens were analyzed using a Leica confocal microscope or a conventional Zeiss-immunofluorescence microscope.
Actin polymerization
Thymocytes and lymph node T cells were incubated with anti-CD3ε (1 µg/ml), anti-CD3ε (1 µg/ml) plus anti-CD28 (1 µg/ml), or anti-CD28 (1 µg/ml) antibody for 30 min on ice. After washing, the primary antibodies were cross-linked using goat anti-hamster Ig (1 µg/ml). As a control, cells were only incubated with the cross-linking antibody. In parallel, cells were activated with PMA (12.5 ng/ml), PMA plus the Ca 2+ ionophore A23617 (100 ng/ml), Ca 2+ ionophore (100 ng/ml), or anti-CD3ε antibody (1 µg/ml) plus Ca 2+ ionophore (100 ng/ml). Activation was stopped by addition of 4% paraformaldehyde. After fixation, cells were incubated with FITC-labeled phalloidin which specifically binds to polymerized F actin, for 30 min, washed three times in PBS, and phalloidin staining was analyzed using a FACScalibur. The proportion increase in F actin was calculated as {the mean value of phalloidin fluorescence intensity of activated cells at a certain time point / mean value of phalloidin fluorescence intensity of control cells treated with the second-stage cross-linking antibody alone at the same time points} × 100%. 
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Figure S3
Vav regulates antigen-receptor capping. Lymph node T cells from vav -/-(upper panels) and vav +/-(lower panels) mice were incubated with anti-CD3ε antibodies (clone 145-2C11, hamster IgG) at 4°C or 37°C for 30 min and cross-linked for 20 min at 4°C or 37°C as described in Figure 4 . CD3 caps were visualized using conventional fluorescence microscopy. Similar results were obtained using thymocytes (data not shown). The magnification is × 320. One result representative of three experiments is shown. 
